3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
9
Carcinoma, Non-Small-Cell Lung
7
Sarcoma
5
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Nasopharyngeal Carcinoma
3
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Whole-Brain Radiotherapy
1
Stomach Neoplasms
1
Solid Tumors
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Proteinuria
1
Progression Free Survival(PFS)
1
Platinum-resistant Ovarian Cancer (PROC)
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Leiomyosarcoma
1
HER2-Negative Breast Cancer
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Extensive Stage Lung Small Cell Cancer
1
Esophageal Neoplasms
1
Interventions
Doxorubicin
5
pembrolizumab
4
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
CTLA-4 Antigen
3
Biopsy
3
cabozantinib
2
Ifosfamide
2
tremelimumab
1
talimogene laherparepvec
1
regorafenib
1
peposertib
1
pazopanib
1
olaratumab
1
liposomal doxorubicin
1
futibatinib
1
fludarabine
1
eribulin
1
durvalumab
1
avelumab
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Standard of Care
1
Quality of Life
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
anlotinib
×
1 year
×
Clear all
No trials found.